Eliglustat
Overview
Eliglustat is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2110588).
API suppliers (3)
Suppliers of Eliglustat evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 2 of 3 suppliers.
1 of 3 holds a GMP certificate on record in the EU or UK registers
- Maithri Laboratories Private LimitedIndia1 active DMF GMP on record
- Apotex Inc.Canada1 active DMF
- BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (3 approved US products), the latest listed US patent on Eliglustat expires 13 Dec 2038. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]octanamide
- Canonical SMILES
- CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O
- InChIKey
- FJZZPCZKBUKGGU-AUSIDOKSSA-N
Do you supply Eliglustat? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.